drugset / Trial / NCT03207295
Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children
Unknown
108 enrolled
China National Center for Cardiovascular Diseases
Tibet Kang Zhe Pharmaceutical Technology Co., Ltd · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Nesiritide, a recombinant human B-type natriuretic peptide, has favorable effects on patient symptoms, hemodynamics, and the neurohumoral profile in adults with decompensated congestive heart failure and in those recovering from cardiac surgery involving cardiopulmonary bypass. Investigators seek to determine whether nesiritide would improve the early postoperative course after total cavo-pulmonary connection surgery in children.
Timeline
- Start
- 2017-07-05
- Primary completion
- 2020-07-01
- Completion
- 2020-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nesiritide | Protein / enzyme biologic | 0.001 ug/kg | — |